
Jagadishwar Rao Samala
Examiner (ID: 8163, Phone: (571)272-9927 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1215 |
| Issued Applications | 815 |
| Pending Applications | 79 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17080692
[patent_doc_number] => 20210275698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/073153
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/073153 | COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME | Oct 15, 2020 | Pending |
Array
(
[id] => 20401310
[patent_doc_number] => 12491270
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Imaging histone deacetylases with a radiotracer using positron emission tomography
[patent_app_type] => utility
[patent_app_number] => 17/066925
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 14
[patent_no_of_words] => 7451
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17066925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/066925 | Imaging histone deacetylases with a radiotracer using positron emission tomography | Oct 8, 2020 | Issued |
Array
(
[id] => 16914039
[patent_doc_number] => 20210187131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/062757
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17062757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/062757 | METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF | Oct 4, 2020 | Abandoned |
Array
(
[id] => 16837977
[patent_doc_number] => 20210145989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS
[patent_app_type] => utility
[patent_app_number] => 17/039409
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17039409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/039409 | COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS | Sep 29, 2020 | Pending |
Array
(
[id] => 18301121
[patent_doc_number] => 11623007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Long-lived gadolinium based tumor targeted imaging and therapy agents
[patent_app_type] => utility
[patent_app_number] => 17/032132
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 8637
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/032132 | Long-lived gadolinium based tumor targeted imaging and therapy agents | Sep 24, 2020 | Issued |
Array
(
[id] => 19089733
[patent_doc_number] => 11951152
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-04-09
[patent_title] => Microparticle compositions for controlled delivery of telmisartan and actinomycin D
[patent_app_type] => utility
[patent_app_number] => 17/025277
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 16
[patent_no_of_words] => 13418
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17025277
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/025277 | Microparticle compositions for controlled delivery of telmisartan and actinomycin D | Sep 17, 2020 | Issued |
Array
(
[id] => 19256908
[patent_doc_number] => 12016937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Composition of radioactive and non-radioactive microparticles
[patent_app_type] => utility
[patent_app_number] => 17/295609
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8209
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295609
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295609 | Composition of radioactive and non-radioactive microparticles | Sep 14, 2020 | Issued |
Array
(
[id] => 17875507
[patent_doc_number] => 11447508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same
[patent_app_type] => utility
[patent_app_number] => 16/997240
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8851
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997240
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997240 | Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same | Aug 18, 2020 | Issued |
Array
(
[id] => 16597937
[patent_doc_number] => 20210024468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => 8-HYDROXYQUINOLINE DERIVATIVES AS DIAGNOSTIC AND THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/997501
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997501
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997501 | 8-hydroxyquinoline derivatives as diagnostic and therapeutic agents | Aug 18, 2020 | Issued |
Array
(
[id] => 18171793
[patent_doc_number] => 11571486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Bilirubin derivative-based diagnostic and therapeutic ultrasound contrast agent
[patent_app_type] => utility
[patent_app_number] => 16/985219
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 6579
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16985219
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/985219 | Bilirubin derivative-based diagnostic and therapeutic ultrasound contrast agent | Aug 3, 2020 | Issued |
Array
(
[id] => 17525651
[patent_doc_number] => 11298317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Alcoholic compositions having a lowered risk of acetaldehydemia
[patent_app_type] => utility
[patent_app_number] => 16/941959
[patent_app_country] => US
[patent_app_date] => 2020-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7650
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16941959
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/941959 | Alcoholic compositions having a lowered risk of acetaldehydemia | Jul 28, 2020 | Issued |
Array
(
[id] => 17974408
[patent_doc_number] => 11491245
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Gadolinium chelate compounds for use in magnetic resonance imaging
[patent_app_type] => utility
[patent_app_number] => 16/947272
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 24768
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16947272
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/947272 | Gadolinium chelate compounds for use in magnetic resonance imaging | Jul 26, 2020 | Issued |
Array
(
[id] => 16581541
[patent_doc_number] => 20210015943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => SILICA NANOSPHERE FOR IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/932380
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16932380
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/932380 | Silica nanosphere for immunotherapy | Jul 16, 2020 | Issued |
Array
(
[id] => 17981263
[patent_doc_number] => 20220347299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => FLUORESCENT SYSTEMS FOR BIOLOGICAL IMAGING AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/597607
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597607
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597607 | FLUORESCENT SYSTEMS FOR BIOLOGICAL IMAGING AND USES THEREOF | Jul 13, 2020 | Pending |
Array
(
[id] => 17836521
[patent_doc_number] => 20220273826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/622058
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622058 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES THEREOF | Jun 29, 2020 | Abandoned |
Array
(
[id] => 18510126
[patent_doc_number] => 20230226227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/622060
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622060
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622060 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES THEREOF | Jun 29, 2020 | Pending |
Array
(
[id] => 17696000
[patent_doc_number] => 11369702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Kits and methods for preparing radiopharmaceuticals
[patent_app_type] => utility
[patent_app_number] => 16/910264
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3227
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16910264
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/910264 | Kits and methods for preparing radiopharmaceuticals | Jun 23, 2020 | Issued |
Array
(
[id] => 16807700
[patent_doc_number] => 20210130253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => PURIFICATION METHOD
[patent_app_type] => utility
[patent_app_number] => 16/903181
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16903181
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/903181 | PURIFICATION METHOD | Jun 15, 2020 | Abandoned |
Array
(
[id] => 17890052
[patent_doc_number] => 11452999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Isotope preparation method
[patent_app_type] => utility
[patent_app_number] => 16/897994
[patent_app_country] => US
[patent_app_date] => 2020-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7732
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897994
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/897994 | Isotope preparation method | Jun 9, 2020 | Issued |
Array
(
[id] => 16326910
[patent_doc_number] => 20200297875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => DEUTERATED COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/895352
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 791
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16895352
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/895352 | Deuterated compounds | Jun 7, 2020 | Issued |